Is inhibition of phosphodiesterase type 5 by sildenafil a promising therapy for volume-overload heart failure?
Wangde
W
Dai
Robert A
RA
Kloner
D000818:Animals; D004195:Disease Models, Animal; D008297:Male; D008944:Mitral Valve Insufficiency / Q000188:drug therapy*; D010805:Physical Conditioning, Animal; D010807:Physical Endurance / Q000187:drug effects*; D010879:Piperazines / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use*; D020257:Ventricular Remodeling / Q000187:drug effects*
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate